The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
Forum Comments on Share Price

Related Posts

Exclusive Interview with Linius Technologies CEO James Brennan

December 1, 2024

Tech 5: NVIDIA Hits Market Cap Milestone, Harmonic...

July 14, 2025

Reinstatement to Quotation

February 6, 2025

California Touts US$540 Billion Salton Sea Lithium Discovery

April 2, 2025

Lawrence Lepard: “Big Print” Coming — Fully Expect...

December 13, 2024

Edison Lithium Expands Portfolio with Acquisition of Additional...

April 17, 2024

First Helium Completes Drilling 7-30 Well & Cases...

January 31, 2025

Pampa Metals Intersects 304m at 1.07% CuEq* incl....

March 17, 2024

David Morgan: Is This a Gold Price Breakout...

December 6, 2023

Brunswick Continues to Intersect Lithium Mineralization on Globex’s...

April 26, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,458)
    • Investing (3,664)
    • Politics (4,922)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved